Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci

Katharina Neudorfer, Suzannah M. Schmidt-Malan, Robin Patel

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We tested the in vitro activity of dalbavancin, vancomycin and daptomycin against 83 enterococcal isolates in planktonic and biofilm states. The MIC90 for vancomycin-susceptible Enterococcus faecalis was 0.125 and 4 μg/mL for dalbavancin and daptomycin, respectively. For vancomycin-resistant Enterococcus faecium, the MIC90 was >16 and 2 μg/mL for dalbavancin and daptomycin, respectively. Dalbavancin minimum biofilm inhibitory concentrations (MBICs) for vancomycin-susceptible and -resistant isolates were ≤0.25 and >16 μg/mL, respectively. The daptomycin MBIC90 for all isolates was 4 μg/mL. For E. faecalis and E. faecium, dalbavancin minimum biofilm bactericidal concentrations (MBBCs) for vancomycin-susceptible and -resistant isolates were ≤4 and >16 μg/mL, respectively, whereas vancomycin MBBCs were >128 μg/mL for all isolates, and daptomycin MBBC90 values for both species were 128 μg/mL. In summary, dalbavancin exhibited in vitro activity against all tested isolates of vancomycin-susceptible, but not against vancomycin-resistant enterococci; activity was observed in both the planktonic and biofilm states.

Original languageEnglish (US)
Pages (from-to)58-63
Number of pages6
JournalDiagnostic Microbiology and Infectious Disease
Volume90
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Daptomycin
Enterococcus
Vancomycin
Biofilms
Enterococcus faecium
Enterococcus faecalis
Microbial Sensitivity Tests
dalbavancin
In Vitro Techniques

Keywords

  • Biofilm
  • Dalbavancin
  • Enterococcus

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci. / Neudorfer, Katharina; Schmidt-Malan, Suzannah M.; Patel, Robin.

In: Diagnostic Microbiology and Infectious Disease, Vol. 90, No. 1, 01.01.2018, p. 58-63.

Research output: Contribution to journalArticle

@article{9b3d1940bdf64c44b66647153f541129,
title = "Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci",
abstract = "We tested the in vitro activity of dalbavancin, vancomycin and daptomycin against 83 enterococcal isolates in planktonic and biofilm states. The MIC90 for vancomycin-susceptible Enterococcus faecalis was 0.125 and 4 μg/mL for dalbavancin and daptomycin, respectively. For vancomycin-resistant Enterococcus faecium, the MIC90 was >16 and 2 μg/mL for dalbavancin and daptomycin, respectively. Dalbavancin minimum biofilm inhibitory concentrations (MBICs) for vancomycin-susceptible and -resistant isolates were ≤0.25 and >16 μg/mL, respectively. The daptomycin MBIC90 for all isolates was 4 μg/mL. For E. faecalis and E. faecium, dalbavancin minimum biofilm bactericidal concentrations (MBBCs) for vancomycin-susceptible and -resistant isolates were ≤4 and >16 μg/mL, respectively, whereas vancomycin MBBCs were >128 μg/mL for all isolates, and daptomycin MBBC90 values for both species were 128 μg/mL. In summary, dalbavancin exhibited in vitro activity against all tested isolates of vancomycin-susceptible, but not against vancomycin-resistant enterococci; activity was observed in both the planktonic and biofilm states.",
keywords = "Biofilm, Dalbavancin, Enterococcus",
author = "Katharina Neudorfer and Schmidt-Malan, {Suzannah M.} and Robin Patel",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.diagmicrobio.2017.09.015",
language = "English (US)",
volume = "90",
pages = "58--63",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci

AU - Neudorfer, Katharina

AU - Schmidt-Malan, Suzannah M.

AU - Patel, Robin

PY - 2018/1/1

Y1 - 2018/1/1

N2 - We tested the in vitro activity of dalbavancin, vancomycin and daptomycin against 83 enterococcal isolates in planktonic and biofilm states. The MIC90 for vancomycin-susceptible Enterococcus faecalis was 0.125 and 4 μg/mL for dalbavancin and daptomycin, respectively. For vancomycin-resistant Enterococcus faecium, the MIC90 was >16 and 2 μg/mL for dalbavancin and daptomycin, respectively. Dalbavancin minimum biofilm inhibitory concentrations (MBICs) for vancomycin-susceptible and -resistant isolates were ≤0.25 and >16 μg/mL, respectively. The daptomycin MBIC90 for all isolates was 4 μg/mL. For E. faecalis and E. faecium, dalbavancin minimum biofilm bactericidal concentrations (MBBCs) for vancomycin-susceptible and -resistant isolates were ≤4 and >16 μg/mL, respectively, whereas vancomycin MBBCs were >128 μg/mL for all isolates, and daptomycin MBBC90 values for both species were 128 μg/mL. In summary, dalbavancin exhibited in vitro activity against all tested isolates of vancomycin-susceptible, but not against vancomycin-resistant enterococci; activity was observed in both the planktonic and biofilm states.

AB - We tested the in vitro activity of dalbavancin, vancomycin and daptomycin against 83 enterococcal isolates in planktonic and biofilm states. The MIC90 for vancomycin-susceptible Enterococcus faecalis was 0.125 and 4 μg/mL for dalbavancin and daptomycin, respectively. For vancomycin-resistant Enterococcus faecium, the MIC90 was >16 and 2 μg/mL for dalbavancin and daptomycin, respectively. Dalbavancin minimum biofilm inhibitory concentrations (MBICs) for vancomycin-susceptible and -resistant isolates were ≤0.25 and >16 μg/mL, respectively. The daptomycin MBIC90 for all isolates was 4 μg/mL. For E. faecalis and E. faecium, dalbavancin minimum biofilm bactericidal concentrations (MBBCs) for vancomycin-susceptible and -resistant isolates were ≤4 and >16 μg/mL, respectively, whereas vancomycin MBBCs were >128 μg/mL for all isolates, and daptomycin MBBC90 values for both species were 128 μg/mL. In summary, dalbavancin exhibited in vitro activity against all tested isolates of vancomycin-susceptible, but not against vancomycin-resistant enterococci; activity was observed in both the planktonic and biofilm states.

KW - Biofilm

KW - Dalbavancin

KW - Enterococcus

UR - http://www.scopus.com/inward/record.url?scp=85035225517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035225517&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2017.09.015

DO - 10.1016/j.diagmicrobio.2017.09.015

M3 - Article

C2 - 29195766

AN - SCOPUS:85035225517

VL - 90

SP - 58

EP - 63

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 1

ER -